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Abstract
Background: Diabetes mellitus (DM) is a metabolic disorder precipitating micro and macro vascular complications 
and peripheral vascular diseases. Normal lung mechanism and gas exchange are influenced by integrity of pulmonary 
connective tissues and microvasculature. Abnormality in either of these two structural components of lung leads to 
variations in lung functions. Objective: This study was conducted to document lung function patterns by spirometry 
in patients with Type 1 DM. Materials and Methods: This cross-sectional study was conducted in Bangalore, India. 
Patients in the age group of 1-18 years diagnosed with Type 1 DM between December 2009, and January 2011 were 
included. Data regarding respiratory symptoms, age, height and weight of each patient with Type 1 DM was collected. 
The children were trained to use spirometers. Multiple readings of forced expiratory volume in one second and forced 
vital capacity were obtained until consistent, and the best reading was recorded and analyzed for any association. 
Results: A total of 51 children with Type 1 DM were studied, of whom 24 children were males, with a mean age of 
14.06 ± 3.25 years, the minimum age being 5 years and a maximum being 18 years. 25 children (49%) with Type 1 
DM were found to have pulmonary dysfunction, of which 19 children (76%) had restrictive lung pattern, and six 
children (24%) had obstructive pattern. Conclusion: Spirometry evaluation showed that restrictive lung pattern was 
very common in children with Type 1 DM, and there is scope for further study.
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Diabetes mellitus (DM), both Type 1 and 2 is a systemic disease that involves multi-organ systems in the body precipitating micro, and 
macro vascular complications and peripheral vascular 
diseases [1]. Less has been known about the after 
effects of DM on lungs. Normal lung mechanism and 
gas exchange are influenced by integrity of pulmonary 
connective tissues and microvasculature. Abnormality 
in either of these two structural components of 
lung leads to variations in the lung functions [1,2]. 
Histopathological evidence in human beings and 
experimental data suggest that the respiratory system 
is affected in Type 1 DM as part of the systemic 
nature of the disease [3]. Although, abnormalities of 
pulmonary functions are described in subjects with 
Type 1 DM, the results have been conflicting and 
inconclusive [4,5]. The most consistent functional 
abnormality reported in the literature is reduced lung 
volume, decreased elastic recoil and impaired gas 
transfer [3]. Spirometry is used to detect abnormalities 
and classify the ventilatory function into obstructive 
or restrictive pulmonary patterns. However, the results 
of spirometry in children with Type 1 DM have been 
quiet inconsistent, some showing no effects, whereas 
others are showing a restrictive pattern and a few with 
obstructive features [6]. There is a need to study the 
association of Type 1 DM with pulmonary function 
abnormalities in pediatric age group in India and hence 
this cross sectional study was undertaken to investigate 
pulmonary function in children with Type 1 DM.
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MATERIALS AND METHODS
This was a cross-sectional study, conducted over a 
period of 14 months after obtaining the approval from 
institutional ethical review board and ICH-GCP 2008 
Seoul amendment and ICMR 2006 guidelines were 
followed during the study procedure. A specially 
designed case record form was used to collect the 
data. Children in the age group 1-18 years with Type 1 
DM diagnosed according to American Diabetes 
Association (ADA) were included in the study [7]. 
According to ADA criteria, patients with age of onset 
below 18 years and requiring insulin for glycemic 
control were clinically diagnosed to have Type 1 DM. 
Children with Type 1 DM attending to outpatient 
department were included in the study after getting 
informed written consent from the patients or their 
guardians. Children with previous and present cardio 
respiratory diseases, known asthmatics or patients with 
symptoms of asthma and smokers were excluded from 
the study. Patient’s gender, age, height in centimeters 
and weight in kilograms, and body mass index (BMI), 
presence or absence of respiratory symptoms and 
family history of Type 1 DM were collected. Details 
including history with special importance to any recent 
history of respiratory symptom such as cold, cough, 
wheezing, exercise induced breathlessness, allergic 
manifestation such as triggering factor, causal factors, 
medications (along with BMI and thorough systemic 
examination) were recorded. Thorough general and 
systemic examination was also performed.
Patients who had a cough received bronchodilators 
within 72 h were excluded. Procedure was explained, 
and spirometry was performed by pulmonary function 
technician who was a certified trainer in lung function 
tests. Results were interpreted by the investigator. 
Spirometer used was TM Diagnostic spirometer C 
Model 2001/manufactured by Ndd medizintechnik AG, 
8005 Zurich. Calibration was carried out periodically 
by the technician. Predictive values were derived from 
advanced spirometry with normograms established for 
Asian children and specifically derived for age/sex and 
ethnic groups. The best of three attempts was taken. 
Following parameters were recorded: Forced vital 
capacity (FVC) in liters, forced expiratory volume 
in one second (FEV1) in liters, and FEV1/FVC ratio 
was calculated. The absolute FEV1 and FVC were 
compared with the predicted FEV1 and FVC, and the 
subjects were categorized into normal, obstructive and 
restrictive pulmonary patterns depending on FEV1/
FVC ratio based on Enright Algorithm (Table 1) [8]. 
Patient showing <80% of expected FEV1 and peak 
expiratory flow rate was considered significant followed 
by bronchodilator challenge in the form of inhaler 
through spacer was given, improvement of more than 
12% from the baseline were taken as obstruction with 
good reversibility and if the results showed FVC <80% 
of expected then it was taken as restrictive.
Data were entered in MS Excel and imported to 
SPSS version 20 for further analysis. Descriptive 
statistics is comprising of mean standard deviation 
(SD) and percentage (Proportions) for continuous and 
dis-contiguous data respectively. Independent t test 
was used to compare mean (SD) of the variables such 
as height, weight, FVC, FEV1 and FEV1/FVC ratio 
between males and females. Statistical significance 
was considered at p < 0.05.
RESULTS
Totally 90 children with Type 1 DM were screened 
for inclusion in our study, but only 51 children were 
studied and remaining excluded due to various 
reasons (Fig. 1). The mean age was 14.06 ± 3.25 years 
with a minimum age of 5 years and a maximum 
age of 18 years. The mean height of the children 
was 144.57 ± 16.35 cm and mean weight was 36.19 
± 12.13 kg. Of the 51 children, 24 (47.05%) were male. 
There was no significant difference in height, weight 
Table 1: Enright Algorithm
Pulmonary 
function
FVC (% of 
lower limit 
of normal)
FEV1/
FVC
FEV1 (% 
of predicted 
value)
Normal >80
Abnormal <80
Obstructive 
lung pattern
<80 <70%
Restrictive 
lung pattern
Mild <80 >70 >80
Moderate <80 >70 50-80
Severe <80 >70 30-50
Very severe <80 >70 <30
FVC: Forced vital capacity, FEV1: Forced 
expiratory volume in one second
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and lung functions between genders (Table 2). Among 
51 children, 25 (49%) had abnormal pulmonary 
functions on spirometry. 19 (76%) of these children 
had restrictive lung pattern while 6 children (24%) 
had obstructive lung pattern. The rest of the 26 (51%) 
children were found to have normal pulmonary 
function on spirometry (Table 3).
In the patients with restrictive lung pattern, 57.89% 
were found to have a moderate restrictive pattern, and 
there was no significant correlation of FEV1/FVC 
ratio with the height for age or Type 1 DM (p > 0.05) 
(Table 4).
DISCUSSION
In the present study, we found that restrictive lung 
pattern was common among children with Type 1 DM 
even with no respiratory symptoms (as patients with 
pre-existing respiratory conditions were excluded 
from the study). Interstitial lung disease, an important 
cause of restrictive lung pattern is very rare among 
pediatric age group [1]. DM as a multi system disease 
involves the lungs in the course of complex phenomena 
it generates. The restrictive lung pattern shown by 
Type 1 DM children in this study may due to be the 
damage caused by DM. It may be the initial stage of 
damage as most of the children did not present with 
respiratory symptoms [3]. The obstructive lung pattern 
may be explained by the possibility of environmental 
factors interfering in the development of disorders like 
asthma mediated by Th1 and Th2 cells, in the same 
individual, due to the absence of immunomodulatory 
mechanisms mediated by interleukin-10 and regulatory 
cells [4]. Only the lung function tests using spirometry, 
a non-invasive tool has shown the warning signals of 
restrictive lung disease. Hence, we recommend the 
use of spirometry at regular intervals in children with 
Type 1 DM to take early necessary steps in preventing 
pulmonary damage due to DM.
Recent studies in animals as well as in human 
diabetes demonstrated biochemical changes at 
the pulmonary level such as the suppression of 
anyline p-hydroxilase, reduction in the activity 
of glutathione-peroxidase, development of NO 
dependent endothelial dysfunction, microsomal 
disorders, increased heparan sulphate at the level of 
vascular basement membrane, increased levels of 
advanced glycation end-products and derangement 
of bronchial mucus production by amyline [2]. 
Structural modifications of the lung parenchyma 
were also observed in diabetes such as narrowing of 
the alveolar space, flattening of alveolar epithelium 
and expansion of interstitium [1]. Besides 
basement membranes of the alveolar epithelium, 
bronchial epithelium and pulmonary capillaries 
are also involved [1,2]. The consequences of local 
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Figure 1: Flow chart of the study
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oxidative stress increased vascular permeability 
and modifications in mucus secretion lead to 
the reduction of pulmonary volumes, pulmonary 
diffusion capacity, elastic recoil, bronchial reactivity 
and bronchodilatation [2,9-11].
This was a cross-sectional study, and hence, we 
could not see the changes happened in lung function 
pattern, the time taken for any changes to occur, the 
role of gender, BMI, duration of DM and glycemic 
control in preventing or reversing the damage of lungs. 
Although, 51 of Type 1 DM is quite good number, 
more number of patients from multiple centers with 
long term follow-up will be required to draw a better 
conclusion.
Table 2: Comparison of parameters between genders
Variable N Mean±SD Standard error of mean p value*
Height (in cm)
Male 24 145.5±18.57 3.73 0.70
Female 27 143.7±14.73 2.83
Weight (in kg)
Male 24 35.5±12.88 2.69 0.71
Female 27 33.8±11.66 2.29
FVC (best) (litres)
Male 24 2.0±0.92 0.19 0.65
Female 27 1.9±0.69 0.13
FEV1 (best) (liters)
Male 24 1.8±0.77 0.18 0.49
Female 27 1.6±0.53 0.12
FEV1 (%)
Male 24 76.4±22.69 5.35 0.63
Female 27 73.1±18.81 4.43
FEV1/FVC ratio
Male 24 83.5±29.84 6.09 0.46
Female 27 77.9±22.99 4.42
FVC: Forced vital capacity, FEV1: Forced expiratory volume in one second, SD: Standard deviation
Table 3: Morbidity pattern
Diagnosis Frequency (%)
Normal 26 (51.0)
Obstructive 6 (11.8)
Restrictive = mild 6 (11.8)
Restrictive = moderate 11 (21.6)
Restrictive = severe 1 (2.0)
Restrictive = very severe 1 (2.0)
Total 51 (100.0)
CONCLUSION
Majority of children with Type 1 DM had restrictive 
lung functions and were asymptomatic in this study. 
Only lung function tests using spirometry has shown 
the warning signals of restrictive lung disease in these 
asymptomatic children. Therefore, we recommend the 
use of spirometry at regular intervals in children with 
Type 1 DM to take early necessary steps in preventing 
pulmonary damage due to DM.
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Table 4: Distribution of Type 1 diabetes patient based on lung functions
Parameters N Minimum Maximum Mean Standard deviation
Height (in cm) 51 93.00 175.00 144.57 16.35
Weight (in kg) 49 9.00 69.00 36.19 12.13
FVC (best) (litres) 51 0.19 3.89 1.94 0.80
FEV1 (best) (litres) 36 0.17 3.63 1.68 0.65
FEV1 (%) 36 26.00 113.00 74.72 20.61
FEV1/FVC ratio 51 28.00 200.00 80.55 26.31
FVC: Forced vital capacity, FEV1: Forced expiratory volume in one second
